← Evidence map

ArticleMolecular therapy. Oncology2025

Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing.

Maxim F Carle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41190236